Posts
Browse articles by their most recent update.
ROIC Study 3: Eoptolink — Fully Priced In
English version awaiting publication. You can read the original article in Chinese.
Read articleROIC Study 4: Zhongyida — A Company to Avoid
English version awaiting publication. You can read the original article in Chinese.
Read articleROIC Study 1: Tongzhou Electronics — Avoid the ROIC Trap
English version awaiting publication. You can read the original article in Chinese.
Read articleXingye Silver & Tin: Executive Summary
English version awaiting publication. You can read the original article in Chinese.
Read articleYOFC (601869.SH / 06869.HK): Comprehensive Due Diligence
English version awaiting publication. You can read the original article in Chinese.
Read articleYOFC (601869.SH): Technical Outlook — Wait and See
English version awaiting publication. You can read the original article in Chinese.
Read articleAfter the Subsidies Recede: Revisiting My Compute Valuation Model
English version awaiting publication. You can read the original article in Chinese.
Read articleRunning Claude Code Locally on a 128GB Mac Studio
English version awaiting publication. You can read the original article in Chinese.
Read articleHengrui Pharma (600276.SH): Watching the Fundamentals
English version awaiting publication. You can read the original article in Chinese.
Read articleHengrui Pharma (600276): May 2026 Bearish Technical Outlook
English version awaiting publication. You can read the original article in Chinese.
Read articleLingrui Pharmaceutical (600285.SH): Bullish Technical Outlook
English version awaiting publication. You can read the original article in Chinese.
Read articleLingrui Pharmaceutical (600285): A Bearish Fundamental View
English version awaiting publication. You can read the original article in Chinese.
Read article